News & Updates

Study: MRE predicts HCC after SVR

A new study in the Journal of Viral Hepatitis found that magnetic resonance elastography (MRE) had much higher accuracy than serum-based markers for predicting risk of hepatocellular carcinoma (HCC) development after sustained virological response (SVR) for Hepatitis C treatment. Monitoring patients for subsequent development of HCC is clinically important, and the usefulness of noninvasive markers for prediction HCC has long been of interest to clinicians and researchers. "This important study demonstrates the clinical utility of MRE for patients who receive direct acting antiviral (DAA) treatment for Hepatitis C," said Richard Ehman, MD, Mayo Clinic Radiologist and CEO of Resoundant. The

Recognizing International NASH Day

During International NASH Day 2019, Resoundant is proud to join the Global Liver Institute (GLI) and many other dedicated clinicians and patients in raising awareness of this life threatening condition. Non-alcoholic steatohepatitis, or NASH, has been called an epidemic, a "ticking time bomb", and a "silent tsunami". It is the progressive form of non-alcoholic fatty liver disease (NAFLD), and affects more than 115 million people worldwide. An estimated 357 million people will be affected by 2030. Because NASH symptoms are not overt, NASH is often underdiagnosed and underreported. NAFLD and NASH are major risk factors for other health conditions: more than 70% of patients are obese, up to 75%

Search News
RSS Feed
  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon

© 2020 by Resoundant, Inc.